Abstract 4911: Collaboration on quality of life in myeloproliferative neoplasms: Analysis of body mass index and symptom burden
Sarah Friis Christensen(Gundersen Health System), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Esben Meulengracht Flachs(Bispebjerg Hospital), Martin Goros(The University of Texas at San Antonio Health Science Center), Hans C. Hasselbalch(Zealand University Hospital), Christen Lykkegaard Andersen(Copenhagen University Hospital), Robyn M. Scherber(Blueprint Medicines (United States)), Nana Brochmann(Zealand University Hospital), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center)
Cited by 1
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k